Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Dec 6;8(12):1934.
doi: 10.3390/microorganisms8121934.

Untapped Potentials of Endophytic Fungi: A Review of Novel Bioactive Compounds with Biological Applications

Affiliations
Review

Untapped Potentials of Endophytic Fungi: A Review of Novel Bioactive Compounds with Biological Applications

Madira Coutlyne Manganyi et al. Microorganisms. .

Abstract

Over the last century, endophytic fungi have gained tremendous attention due to their ability to produce novel bioactive compounds exhibiting varied biological properties and are, therefore, utilized for medicinal, pharmaceutical, and agricultural applications. Endophytic fungi reside within the plant tissues without showing any disease symptoms, thus supporting the physiological and ecological attributes of the host plant. Ground breaking lead compounds, such as paclitaxel and penicillin, produced by endophytic fungi have paved the way for exploring novel bioactive compounds for commercial usage. Despite this, limited research has been conducted in this valuable and unique niche area. These bioactive compounds belong to various structural groups, including alkaloids, peptides, steroids, terpenoids, phenols, quinones, phenols, and flavonoids. The current review focuses on the significance of endophytic fungi in producing novel bioactive compounds possessing a variety of biological properties that include antibacterial, antiviral, antifungal, antiprotozoal, antiparasitic, antioxidant, immunosuppressant, and anticancer functions. Taking into consideration the portal of this publication, special emphasis is placed on the antimicrobial and antiviral activities of metabolites produced by endophytes against human pathogens. It also highlights the importance of utilization of these compounds as potential treatment agents for serious life-threatening infectious diseases. This is supported by the fact that several findings have indicated that these bioactive compounds may significantly contribute towards the fight against resistant human and plant pathogens, thus motivating the need enhance the search for new, more efficacious and cost-effective antimicrobial drugs.

Keywords: bioactive compounds; biological activities; discovery; endophytic fungi; novel.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Timeline of events in the development of antibiotic resistance [23].
Figure 2
Figure 2
Chemical structures of the bioactive compounds with antibacterial activities [32,33].
Figure 2
Figure 2
Chemical structures of the bioactive compounds with antibacterial activities [32,33].
Figure 3
Figure 3
Chemical structures of the bioactive compounds with antifungal activities [33].
Figure 4
Figure 4
Chemical structures of the bioactive compounds with anticancer activities [25,44,54].
Figure 4
Figure 4
Chemical structures of the bioactive compounds with anticancer activities [25,44,54].
Figure 5
Figure 5
Chemical structures of the bioactive compounds with antioxidant activities [12].
Figure 5
Figure 5
Chemical structures of the bioactive compounds with antioxidant activities [12].
Figure 6
Figure 6
Chemical structures of the bioactive compounds with antiparasitic activities [20].
Figure 7
Figure 7
Chemical structures of the bioactive compounds with immunosuppressive activities [99].
Figure 8
Figure 8
Chemical structures of the bioactive compounds with antiviral activities [12,20,25].
Figure 9
Figure 9
Chemical structures of bioactive compounds with antituberculosis activities [12,20,69].

References

    1. Ayukekbong J.A., Ntemgwa M., Atabe A.N. The threat of antimicrobial resistance in developing countries: Causes and control strategies. Antimicrob. Resist. Infect. Control. 2017;6:47. doi: 10.1186/s13756-017-0208-x. - DOI - PMC - PubMed
    1. Dadgostar P. Antimicrobial Resistance: Implications and Costs. Infect. Drug Resist. 2019;12:3903–3910. doi: 10.2147/IDR.S234610. - DOI - PMC - PubMed
    1. Vasan N., Baselga J., Hyman D.M. A view on drug resistance in cancer. Nature. 2019;575:299–309. doi: 10.1038/s41586-019-1730-1. - DOI - PMC - PubMed
    1. Prestinaci F., Pezzotti P., Pantosti A. Antimicrobial resistance: A global multifaceted phenomenon. Pathog. Glob. Health. 2015;109:309–318. doi: 10.1179/2047773215Y.0000000030. - DOI - PMC - PubMed
    1. World Health Organization (WHO) Antimicrobial Resistance: Global Report on Surveillance. WHO; Geneva, Switzerland: 2014.

LinkOut - more resources